Myofascial Pain, Myofascial Trigger Point Pain, Trigger Point Pain, Myofascial
Conditions
Keywords
usg-guided trigger point injections, myofascial pain, myofascial trigger point, fascial hydrodilatation
Brief summary
In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.
Detailed description
This study aims to compare the intramuscular trigger point injection, which is traditionally used in the treatment of myofascial trigger points with the method in which facial layers are also included in the application.
Interventions
PROCEDUREmyo + fascial injection
10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described.
PROCEDUREtraditional trigger point injection
10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described.
Sponsors
Bozyaka Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Intervention model description
This study is planned to compare the effects of USG guided intramuscular trigger point injection with the effects of USG guided intramuscular plus fascial trigger point injection. This is a single-center randomized trial with 2 parallel arms.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Pain in the upper back area Detection of active trigger point in upper back muscles (trapezius, levator scapula, rhomboids, supraspinatus and infraspinatus) Presence of at least two of the three criteria recommended for the diagnosis of trigger point: 1. Taut band 2. Hypersensitive point 3. Referred pain Pain VAS score ≥ 4 Between the ages of 18-65 -
Exclusion criteria
Using analgesics or anti-inflammatory medicines. Having received physical therapy for the same symptoms in the past 3 months Serious psychiatric illness Presence of malignancy or infection Coagulation disorder Pregnancy History of operation in the relevant region Presence of fibromyalgia syndrome History of allergy to local anesthetics \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VAS(Visual Analog Scale) | Baseline | Pain intensity will be evaluated with the visual analog scale (VAS). VAS is a scale used to digitize subjective values such as behavior or characteristics that cannot be measured directly. Two end definitions of the parameter to be evaluated are written on both ends of a 10 cm line and the patient is asked to indicate where his/her condition is appropriate on this line by drawing a line (0. : no pain, 10: very severe pain) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pressure Pain Threshold | Baseline | The Baseline 1200-303 (Push-Pull Force Gauge®, Fabrication Enterprises, Inc.) algometer will be used to measure pressure pain threshold. The Baseline 1200-3031 cm2 is a dynamometer applied with a flat tip. The device is brought into contact with the skin at an angle of 90º and a force is applied to provide an increase of 1 kg per second. The first value at which the patient feels the sensation of pain is recorded. The average of 3 measurements taken at 30-second intervals is recorded as the patient's pressure pain threshold |
| Functional Status | Baseline | The change in the functional status of the patients will be evaluated with the neck disability index (NDI). NDI is a 10-question questionnaire most commonly used to evaluate nonspecific mechanical neck pain. A total score between 0 and 50 is obtained by scoring each question between 0 (no disability) and 5 (complete disability). The validity and reliability study of the Turkish version of the scale was shown. |
Countries
Turkey (Türkiye)
Outcome results
None listed